nodes	percent_of_prediction	percent_of_DWPC	metapath
Histamine Phosphate—SLC22A2—Cytarabine—lymphatic system cancer	0.225	0.291	CbGbCtD
Histamine Phosphate—SLC22A1—Cytarabine—lymphatic system cancer	0.196	0.252	CbGbCtD
Histamine Phosphate—SLC22A3—Vincristine—lymphatic system cancer	0.18	0.233	CbGbCtD
Histamine Phosphate—CYP2C9—Teniposide—lymphatic system cancer	0.0608	0.0785	CbGbCtD
Histamine Phosphate—CYP3A4—Cytarabine—lymphatic system cancer	0.0359	0.0463	CbGbCtD
Histamine Phosphate—CYP3A4—Teniposide—lymphatic system cancer	0.0354	0.0456	CbGbCtD
Histamine Phosphate—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0247	0.0319	CbGbCtD
Histamine Phosphate—CYP3A4—Vincristine—lymphatic system cancer	0.017	0.022	CbGbCtD
Histamine Phosphate—Dyspepsia—Fludarabine—lymphatic system cancer	0.00065	0.00288	CcSEcCtD
Histamine Phosphate—Dysarthria—Methotrexate—lymphatic system cancer	0.000649	0.00288	CcSEcCtD
Histamine Phosphate—Decreased appetite—Fludarabine—lymphatic system cancer	0.000642	0.00285	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000638	0.00283	CcSEcCtD
Histamine Phosphate—Fatigue—Fludarabine—lymphatic system cancer	0.000637	0.00282	CcSEcCtD
Histamine Phosphate—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000632	0.0028	CcSEcCtD
Histamine Phosphate—Constipation—Fludarabine—lymphatic system cancer	0.000632	0.0028	CcSEcCtD
Histamine Phosphate—Pain—Fludarabine—lymphatic system cancer	0.000632	0.0028	CcSEcCtD
Histamine Phosphate—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000624	0.00277	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Teniposide—lymphatic system cancer	0.000619	0.00275	CcSEcCtD
Histamine Phosphate—Flushing—Carmustine—lymphatic system cancer	0.000617	0.00274	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000616	0.00273	CcSEcCtD
Histamine Phosphate—Anaemia—Bleomycin—lymphatic system cancer	0.000613	0.00272	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000609	0.0027	CcSEcCtD
Histamine Phosphate—Asthenia—Teniposide—lymphatic system cancer	0.000603	0.00267	CcSEcCtD
Histamine Phosphate—Malaise—Bleomycin—lymphatic system cancer	0.000598	0.00265	CcSEcCtD
Histamine Phosphate—Pruritus—Teniposide—lymphatic system cancer	0.000595	0.00264	CcSEcCtD
Histamine Phosphate—Arrhythmia—Carmustine—lymphatic system cancer	0.000594	0.00264	CcSEcCtD
Histamine Phosphate—Leukopenia—Bleomycin—lymphatic system cancer	0.000594	0.00263	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Vincristine—lymphatic system cancer	0.000589	0.00261	CcSEcCtD
Histamine Phosphate—Body temperature increased—Fludarabine—lymphatic system cancer	0.000584	0.00259	CcSEcCtD
Histamine Phosphate—Mental disorder—Carmustine—lymphatic system cancer	0.000583	0.00259	CcSEcCtD
Histamine Phosphate—Erythema—Carmustine—lymphatic system cancer	0.000579	0.00257	CcSEcCtD
Histamine Phosphate—Malnutrition—Carmustine—lymphatic system cancer	0.000579	0.00257	CcSEcCtD
Histamine Phosphate—Cough—Bleomycin—lymphatic system cancer	0.000579	0.00257	CcSEcCtD
Histamine Phosphate—Angiopathy—Vincristine—lymphatic system cancer	0.000576	0.00256	CcSEcCtD
Histamine Phosphate—Diarrhoea—Teniposide—lymphatic system cancer	0.000575	0.00255	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000572	0.00254	CcSEcCtD
Histamine Phosphate—Chest pain—Bleomycin—lymphatic system cancer	0.000565	0.00251	CcSEcCtD
Histamine Phosphate—Myalgia—Bleomycin—lymphatic system cancer	0.000565	0.00251	CcSEcCtD
Histamine Phosphate—Back pain—Carmustine—lymphatic system cancer	0.00056	0.00249	CcSEcCtD
Histamine Phosphate—Discomfort—Bleomycin—lymphatic system cancer	0.000558	0.00248	CcSEcCtD
Histamine Phosphate—Mental disorder—Vincristine—lymphatic system cancer	0.000556	0.00247	CcSEcCtD
Histamine Phosphate—Chills—Mitoxantrone—lymphatic system cancer	0.000555	0.00246	CcSEcCtD
Histamine Phosphate—Neoplasm—Methotrexate—lymphatic system cancer	0.000555	0.00246	CcSEcCtD
Histamine Phosphate—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000553	0.00245	CcSEcCtD
Histamine Phosphate—Confusional state—Bleomycin—lymphatic system cancer	0.000546	0.00242	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000544	0.00241	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000542	0.0024	CcSEcCtD
Histamine Phosphate—Erythema—Mitoxantrone—lymphatic system cancer	0.000538	0.00239	CcSEcCtD
Histamine Phosphate—Infection—Bleomycin—lymphatic system cancer	0.000538	0.00239	CcSEcCtD
Histamine Phosphate—Anaemia—Carmustine—lymphatic system cancer	0.000535	0.00237	CcSEcCtD
Histamine Phosphate—Back pain—Vincristine—lymphatic system cancer	0.000535	0.00237	CcSEcCtD
Histamine Phosphate—Vomiting—Teniposide—lymphatic system cancer	0.000534	0.00237	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00053	0.00235	CcSEcCtD
Histamine Phosphate—Asthenia—Fludarabine—lymphatic system cancer	0.00053	0.00235	CcSEcCtD
Histamine Phosphate—Rash—Teniposide—lymphatic system cancer	0.00053	0.00235	CcSEcCtD
Histamine Phosphate—Dermatitis—Teniposide—lymphatic system cancer	0.000529	0.00235	CcSEcCtD
Histamine Phosphate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000527	0.00234	CcSEcCtD
Histamine Phosphate—Headache—Teniposide—lymphatic system cancer	0.000526	0.00234	CcSEcCtD
Histamine Phosphate—Pruritus—Fludarabine—lymphatic system cancer	0.000523	0.00232	CcSEcCtD
Histamine Phosphate—Back pain—Mitoxantrone—lymphatic system cancer	0.000521	0.00231	CcSEcCtD
Histamine Phosphate—Leukopenia—Carmustine—lymphatic system cancer	0.000518	0.0023	CcSEcCtD
Histamine Phosphate—Anorexia—Bleomycin—lymphatic system cancer	0.000516	0.00229	CcSEcCtD
Histamine Phosphate—Anaemia—Vincristine—lymphatic system cancer	0.000511	0.00227	CcSEcCtD
Histamine Phosphate—Hypotension—Bleomycin—lymphatic system cancer	0.000506	0.00224	CcSEcCtD
Histamine Phosphate—Diarrhoea—Fludarabine—lymphatic system cancer	0.000505	0.00224	CcSEcCtD
Histamine Phosphate—Convulsion—Carmustine—lymphatic system cancer	0.000502	0.00223	CcSEcCtD
Histamine Phosphate—Hypertension—Carmustine—lymphatic system cancer	0.0005	0.00222	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0005	0.00222	CcSEcCtD
Histamine Phosphate—Nausea—Teniposide—lymphatic system cancer	0.000499	0.00221	CcSEcCtD
Histamine Phosphate—Anaemia—Mitoxantrone—lymphatic system cancer	0.000498	0.00221	CcSEcCtD
Histamine Phosphate—Vertigo—Vincristine—lymphatic system cancer	0.000497	0.0022	CcSEcCtD
Histamine Phosphate—Leukopenia—Vincristine—lymphatic system cancer	0.000495	0.0022	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000493	0.00219	CcSEcCtD
Histamine Phosphate—Chest pain—Carmustine—lymphatic system cancer	0.000493	0.00219	CcSEcCtD
Histamine Phosphate—Myalgia—Carmustine—lymphatic system cancer	0.000493	0.00219	CcSEcCtD
Histamine Phosphate—Anxiety—Carmustine—lymphatic system cancer	0.000491	0.00218	CcSEcCtD
Histamine Phosphate—Paraesthesia—Bleomycin—lymphatic system cancer	0.000486	0.00216	CcSEcCtD
Histamine Phosphate—Malaise—Mitoxantrone—lymphatic system cancer	0.000486	0.00215	CcSEcCtD
Histamine Phosphate—Dyspnoea—Bleomycin—lymphatic system cancer	0.000483	0.00214	CcSEcCtD
Histamine Phosphate—Renal failure acute—Methotrexate—lymphatic system cancer	0.000483	0.00214	CcSEcCtD
Histamine Phosphate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000482	0.00214	CcSEcCtD
Histamine Phosphate—Convulsion—Vincristine—lymphatic system cancer	0.000479	0.00212	CcSEcCtD
Histamine Phosphate—Hypertension—Vincristine—lymphatic system cancer	0.000477	0.00212	CcSEcCtD
Histamine Phosphate—Confusional state—Carmustine—lymphatic system cancer	0.000477	0.00211	CcSEcCtD
Histamine Phosphate—Decreased appetite—Bleomycin—lymphatic system cancer	0.000471	0.00209	CcSEcCtD
Histamine Phosphate—Myalgia—Vincristine—lymphatic system cancer	0.000471	0.00209	CcSEcCtD
Histamine Phosphate—Cough—Mitoxantrone—lymphatic system cancer	0.00047	0.00208	CcSEcCtD
Histamine Phosphate—Infection—Carmustine—lymphatic system cancer	0.00047	0.00208	CcSEcCtD
Histamine Phosphate—Vomiting—Fludarabine—lymphatic system cancer	0.00047	0.00208	CcSEcCtD
Histamine Phosphate—Convulsion—Mitoxantrone—lymphatic system cancer	0.000467	0.00207	CcSEcCtD
Histamine Phosphate—Rash—Fludarabine—lymphatic system cancer	0.000466	0.00207	CcSEcCtD
Histamine Phosphate—Dermatitis—Fludarabine—lymphatic system cancer	0.000465	0.00206	CcSEcCtD
Histamine Phosphate—Hypertension—Mitoxantrone—lymphatic system cancer	0.000465	0.00206	CcSEcCtD
Histamine Phosphate—Pain—Bleomycin—lymphatic system cancer	0.000463	0.00205	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000463	0.00205	CcSEcCtD
Histamine Phosphate—Headache—Fludarabine—lymphatic system cancer	0.000463	0.00205	CcSEcCtD
Histamine Phosphate—Tachycardia—Carmustine—lymphatic system cancer	0.000461	0.00205	CcSEcCtD
Histamine Phosphate—Myalgia—Mitoxantrone—lymphatic system cancer	0.000458	0.00203	CcSEcCtD
Histamine Phosphate—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000458	0.00203	CcSEcCtD
Histamine Phosphate—Chest pain—Mitoxantrone—lymphatic system cancer	0.000458	0.00203	CcSEcCtD
Histamine Phosphate—Anxiety—Mitoxantrone—lymphatic system cancer	0.000457	0.00203	CcSEcCtD
Histamine Phosphate—Discomfort—Mitoxantrone—lymphatic system cancer	0.000453	0.00201	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000451	0.002	CcSEcCtD
Histamine Phosphate—Anorexia—Carmustine—lymphatic system cancer	0.000451	0.002	CcSEcCtD
Histamine Phosphate—Infection—Vincristine—lymphatic system cancer	0.000448	0.00199	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000446	0.00198	CcSEcCtD
Histamine Phosphate—Confusional state—Mitoxantrone—lymphatic system cancer	0.000443	0.00197	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Vincristine—lymphatic system cancer	0.000443	0.00196	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000442	0.00196	CcSEcCtD
Histamine Phosphate—Hypotension—Carmustine—lymphatic system cancer	0.000442	0.00196	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000439	0.00195	CcSEcCtD
Histamine Phosphate—Nausea—Fludarabine—lymphatic system cancer	0.000439	0.00195	CcSEcCtD
Histamine Phosphate—Infection—Mitoxantrone—lymphatic system cancer	0.000437	0.00194	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000436	0.00193	CcSEcCtD
Histamine Phosphate—Shock—Mitoxantrone—lymphatic system cancer	0.000432	0.00192	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000431	0.00191	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00043	0.00191	CcSEcCtD
Histamine Phosphate—Urticaria—Bleomycin—lymphatic system cancer	0.00043	0.00191	CcSEcCtD
Histamine Phosphate—Anorexia—Vincristine—lymphatic system cancer	0.00043	0.00191	CcSEcCtD
Histamine Phosphate—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000429	0.0019	CcSEcCtD
Histamine Phosphate—Body temperature increased—Bleomycin—lymphatic system cancer	0.000428	0.0019	CcSEcCtD
Histamine Phosphate—Insomnia—Carmustine—lymphatic system cancer	0.000428	0.0019	CcSEcCtD
Histamine Phosphate—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000427	0.00189	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000425	0.00188	CcSEcCtD
Histamine Phosphate—Paraesthesia—Carmustine—lymphatic system cancer	0.000424	0.00188	CcSEcCtD
Histamine Phosphate—Hypotension—Vincristine—lymphatic system cancer	0.000422	0.00187	CcSEcCtD
Histamine Phosphate—Dyspnoea—Carmustine—lymphatic system cancer	0.000421	0.00187	CcSEcCtD
Histamine Phosphate—Anorexia—Mitoxantrone—lymphatic system cancer	0.000419	0.00186	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000411	0.00182	CcSEcCtD
Histamine Phosphate—Decreased appetite—Carmustine—lymphatic system cancer	0.000411	0.00182	CcSEcCtD
Histamine Phosphate—Hypotension—Mitoxantrone—lymphatic system cancer	0.000411	0.00182	CcSEcCtD
Histamine Phosphate—Insomnia—Vincristine—lymphatic system cancer	0.000408	0.00181	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000408	0.00181	CcSEcCtD
Histamine Phosphate—Paraesthesia—Vincristine—lymphatic system cancer	0.000405	0.0018	CcSEcCtD
Histamine Phosphate—Pain—Carmustine—lymphatic system cancer	0.000404	0.00179	CcSEcCtD
Histamine Phosphate—Constipation—Carmustine—lymphatic system cancer	0.000404	0.00179	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.0004	0.00178	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000399	0.00177	CcSEcCtD
Histamine Phosphate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000395	0.00175	CcSEcCtD
Histamine Phosphate—Decreased appetite—Vincristine—lymphatic system cancer	0.000392	0.00174	CcSEcCtD
Histamine Phosphate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000392	0.00174	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00039	0.00173	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00039	0.00173	CcSEcCtD
Histamine Phosphate—Fatigue—Vincristine—lymphatic system cancer	0.000389	0.00173	CcSEcCtD
Histamine Phosphate—Asthenia—Bleomycin—lymphatic system cancer	0.000389	0.00172	CcSEcCtD
Histamine Phosphate—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000387	0.00172	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000387	0.00171	CcSEcCtD
Histamine Phosphate—Constipation—Vincristine—lymphatic system cancer	0.000386	0.00171	CcSEcCtD
Histamine Phosphate—Pain—Vincristine—lymphatic system cancer	0.000386	0.00171	CcSEcCtD
Histamine Phosphate—Asthma—Methotrexate—lymphatic system cancer	0.000385	0.00171	CcSEcCtD
Histamine Phosphate—Pruritus—Bleomycin—lymphatic system cancer	0.000383	0.0017	CcSEcCtD
Histamine Phosphate—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000382	0.00169	CcSEcCtD
Histamine Phosphate—Eosinophilia—Methotrexate—lymphatic system cancer	0.000381	0.00169	CcSEcCtD
Histamine Phosphate—Fatigue—Mitoxantrone—lymphatic system cancer	0.000379	0.00168	CcSEcCtD
Histamine Phosphate—Pain—Mitoxantrone—lymphatic system cancer	0.000376	0.00167	CcSEcCtD
Histamine Phosphate—Constipation—Mitoxantrone—lymphatic system cancer	0.000376	0.00167	CcSEcCtD
Histamine Phosphate—Abdominal pain—Carmustine—lymphatic system cancer	0.000374	0.00166	CcSEcCtD
Histamine Phosphate—Body temperature increased—Carmustine—lymphatic system cancer	0.000374	0.00166	CcSEcCtD
Histamine Phosphate—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000369	0.00164	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000369	0.00164	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000362	0.00161	CcSEcCtD
Histamine Phosphate—Neutropenia—Methotrexate—lymphatic system cancer	0.00036	0.0016	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000359	0.00159	CcSEcCtD
Histamine Phosphate—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000358	0.00159	CcSEcCtD
Histamine Phosphate—Abdominal pain—Vincristine—lymphatic system cancer	0.000357	0.00158	CcSEcCtD
Histamine Phosphate—Body temperature increased—Vincristine—lymphatic system cancer	0.000357	0.00158	CcSEcCtD
Histamine Phosphate—Urticaria—Mitoxantrone—lymphatic system cancer	0.000349	0.00155	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Carmustine—lymphatic system cancer	0.000348	0.00154	CcSEcCtD
Histamine Phosphate—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000347	0.00154	CcSEcCtD
Histamine Phosphate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000347	0.00154	CcSEcCtD
Histamine Phosphate—Pneumonia—Methotrexate—lymphatic system cancer	0.000345	0.00153	CcSEcCtD
Histamine Phosphate—Vomiting—Bleomycin—lymphatic system cancer	0.000344	0.00153	CcSEcCtD
Histamine Phosphate—Infestation—Methotrexate—lymphatic system cancer	0.000343	0.00152	CcSEcCtD
Histamine Phosphate—Infestation NOS—Methotrexate—lymphatic system cancer	0.000343	0.00152	CcSEcCtD
Histamine Phosphate—Rash—Bleomycin—lymphatic system cancer	0.000341	0.00151	CcSEcCtD
Histamine Phosphate—Dermatitis—Bleomycin—lymphatic system cancer	0.000341	0.00151	CcSEcCtD
Histamine Phosphate—Asthenia—Carmustine—lymphatic system cancer	0.000339	0.0015	CcSEcCtD
Histamine Phosphate—Renal failure—Methotrexate—lymphatic system cancer	0.000337	0.0015	CcSEcCtD
Histamine Phosphate—Stomatitis—Methotrexate—lymphatic system cancer	0.000335	0.00148	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Vincristine—lymphatic system cancer	0.000332	0.00147	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000324	0.00144	CcSEcCtD
Histamine Phosphate—Asthenia—Vincristine—lymphatic system cancer	0.000324	0.00144	CcSEcCtD
Histamine Phosphate—Diarrhoea—Carmustine—lymphatic system cancer	0.000323	0.00143	CcSEcCtD
Histamine Phosphate—Nausea—Bleomycin—lymphatic system cancer	0.000322	0.00143	CcSEcCtD
Histamine Phosphate—Asthenia—Mitoxantrone—lymphatic system cancer	0.000315	0.0014	CcSEcCtD
Histamine Phosphate—Dizziness—Carmustine—lymphatic system cancer	0.000313	0.00139	CcSEcCtD
Histamine Phosphate—Diarrhoea—Vincristine—lymphatic system cancer	0.000309	0.00137	CcSEcCtD
Histamine Phosphate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000301	0.00133	CcSEcCtD
Histamine Phosphate—Vomiting—Carmustine—lymphatic system cancer	0.000301	0.00133	CcSEcCtD
Histamine Phosphate—Dizziness—Vincristine—lymphatic system cancer	0.000298	0.00132	CcSEcCtD
Histamine Phosphate—Rash—Carmustine—lymphatic system cancer	0.000298	0.00132	CcSEcCtD
Histamine Phosphate—Dermatitis—Carmustine—lymphatic system cancer	0.000298	0.00132	CcSEcCtD
Histamine Phosphate—Headache—Carmustine—lymphatic system cancer	0.000296	0.00131	CcSEcCtD
Histamine Phosphate—Vomiting—Vincristine—lymphatic system cancer	0.000287	0.00127	CcSEcCtD
Histamine Phosphate—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000286	0.00127	CcSEcCtD
Histamine Phosphate—Rash—Vincristine—lymphatic system cancer	0.000285	0.00126	CcSEcCtD
Histamine Phosphate—Dermatitis—Vincristine—lymphatic system cancer	0.000284	0.00126	CcSEcCtD
Histamine Phosphate—Headache—Vincristine—lymphatic system cancer	0.000283	0.00125	CcSEcCtD
Histamine Phosphate—Nausea—Carmustine—lymphatic system cancer	0.000281	0.00125	CcSEcCtD
Histamine Phosphate—Angiopathy—Methotrexate—lymphatic system cancer	0.00028	0.00124	CcSEcCtD
Histamine Phosphate—Vomiting—Mitoxantrone—lymphatic system cancer	0.000279	0.00124	CcSEcCtD
Histamine Phosphate—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000278	0.00123	CcSEcCtD
Histamine Phosphate—Rash—Mitoxantrone—lymphatic system cancer	0.000277	0.00123	CcSEcCtD
Histamine Phosphate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000277	0.00123	CcSEcCtD
Histamine Phosphate—Chills—Methotrexate—lymphatic system cancer	0.000277	0.00123	CcSEcCtD
Histamine Phosphate—Headache—Mitoxantrone—lymphatic system cancer	0.000275	0.00122	CcSEcCtD
Histamine Phosphate—Mental disorder—Methotrexate—lymphatic system cancer	0.00027	0.0012	CcSEcCtD
Histamine Phosphate—Erythema—Methotrexate—lymphatic system cancer	0.000268	0.00119	CcSEcCtD
Histamine Phosphate—Malnutrition—Methotrexate—lymphatic system cancer	0.000268	0.00119	CcSEcCtD
Histamine Phosphate—Nausea—Vincristine—lymphatic system cancer	0.000268	0.00119	CcSEcCtD
Histamine Phosphate—Dysgeusia—Methotrexate—lymphatic system cancer	0.000263	0.00117	CcSEcCtD
Histamine Phosphate—Nausea—Mitoxantrone—lymphatic system cancer	0.000261	0.00116	CcSEcCtD
Histamine Phosphate—Back pain—Methotrexate—lymphatic system cancer	0.00026	0.00115	CcSEcCtD
Histamine Phosphate—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000249	0.0011	CcSEcCtD
Histamine Phosphate—Anaemia—Methotrexate—lymphatic system cancer	0.000248	0.0011	CcSEcCtD
Histamine Phosphate—Malaise—Methotrexate—lymphatic system cancer	0.000242	0.00107	CcSEcCtD
Histamine Phosphate—Vertigo—Methotrexate—lymphatic system cancer	0.000241	0.00107	CcSEcCtD
Histamine Phosphate—Leukopenia—Methotrexate—lymphatic system cancer	0.00024	0.00107	CcSEcCtD
Histamine Phosphate—Cough—Methotrexate—lymphatic system cancer	0.000234	0.00104	CcSEcCtD
Histamine Phosphate—Convulsion—Methotrexate—lymphatic system cancer	0.000232	0.00103	CcSEcCtD
Histamine Phosphate—Arthralgia—Methotrexate—lymphatic system cancer	0.000228	0.00101	CcSEcCtD
Histamine Phosphate—Myalgia—Methotrexate—lymphatic system cancer	0.000228	0.00101	CcSEcCtD
Histamine Phosphate—Chest pain—Methotrexate—lymphatic system cancer	0.000228	0.00101	CcSEcCtD
Histamine Phosphate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000227	0.00101	CcSEcCtD
Histamine Phosphate—Discomfort—Methotrexate—lymphatic system cancer	0.000226	0.001	CcSEcCtD
Histamine Phosphate—Confusional state—Methotrexate—lymphatic system cancer	0.000221	0.000979	CcSEcCtD
Histamine Phosphate—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000219	0.000971	CcSEcCtD
Histamine Phosphate—Infection—Methotrexate—lymphatic system cancer	0.000218	0.000965	CcSEcCtD
Histamine Phosphate—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000215	0.000952	CcSEcCtD
Histamine Phosphate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000214	0.000951	CcSEcCtD
Histamine Phosphate—Skin disorder—Methotrexate—lymphatic system cancer	0.000213	0.000943	CcSEcCtD
Histamine Phosphate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000212	0.000939	CcSEcCtD
Histamine Phosphate—Anorexia—Methotrexate—lymphatic system cancer	0.000209	0.000926	CcSEcCtD
Histamine Phosphate—Hypotension—Methotrexate—lymphatic system cancer	0.000205	0.000908	CcSEcCtD
Histamine Phosphate—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000199	0.000885	CcSEcCtD
Histamine Phosphate—Insomnia—Methotrexate—lymphatic system cancer	0.000198	0.000878	CcSEcCtD
Histamine Phosphate—Paraesthesia—Methotrexate—lymphatic system cancer	0.000197	0.000872	CcSEcCtD
Histamine Phosphate—Dyspnoea—Methotrexate—lymphatic system cancer	0.000195	0.000866	CcSEcCtD
Histamine Phosphate—Dyspepsia—Methotrexate—lymphatic system cancer	0.000193	0.000855	CcSEcCtD
Histamine Phosphate—Decreased appetite—Methotrexate—lymphatic system cancer	0.00019	0.000844	CcSEcCtD
Histamine Phosphate—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000189	0.000838	CcSEcCtD
Histamine Phosphate—Fatigue—Methotrexate—lymphatic system cancer	0.000189	0.000837	CcSEcCtD
Histamine Phosphate—Pain—Methotrexate—lymphatic system cancer	0.000187	0.000831	CcSEcCtD
Histamine Phosphate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00018	0.0008	CcSEcCtD
Histamine Phosphate—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000179	0.000794	CcSEcCtD
Histamine Phosphate—Urticaria—Methotrexate—lymphatic system cancer	0.000174	0.000772	CcSEcCtD
Histamine Phosphate—Abdominal pain—Methotrexate—lymphatic system cancer	0.000173	0.000768	CcSEcCtD
Histamine Phosphate—Body temperature increased—Methotrexate—lymphatic system cancer	0.000173	0.000768	CcSEcCtD
Histamine Phosphate—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000161	0.000716	CcSEcCtD
Histamine Phosphate—Asthenia—Methotrexate—lymphatic system cancer	0.000157	0.000697	CcSEcCtD
Histamine Phosphate—Pruritus—Methotrexate—lymphatic system cancer	0.000155	0.000687	CcSEcCtD
Histamine Phosphate—Diarrhoea—Methotrexate—lymphatic system cancer	0.00015	0.000665	CcSEcCtD
Histamine Phosphate—Dizziness—Methotrexate—lymphatic system cancer	0.000145	0.000642	CcSEcCtD
Histamine Phosphate—Vomiting—Methotrexate—lymphatic system cancer	0.000139	0.000618	CcSEcCtD
Histamine Phosphate—Rash—Methotrexate—lymphatic system cancer	0.000138	0.000612	CcSEcCtD
Histamine Phosphate—Dermatitis—Methotrexate—lymphatic system cancer	0.000138	0.000612	CcSEcCtD
Histamine Phosphate—Headache—Methotrexate—lymphatic system cancer	0.000137	0.000608	CcSEcCtD
Histamine Phosphate—Nausea—Methotrexate—lymphatic system cancer	0.00013	0.000577	CcSEcCtD
